ANNE PAINTER: Open Payments
NPI 1174971253 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 24 payments from 9 companies in 2025. Trend: 2023 $156 · 2024 $740 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 10 | $138 |
| Janssen Biotech, Inc. | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| GENZYME CORPORATION | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: ZENPEP, TREMFYA, XIFAXAN, DUPIXENT, ENTYVIO, PIFELTRO, VOQUEZNA, Wegovy.
Industry payments across TN — which companies pay providers there.
